113 related articles for article (PubMed ID: 20980466)
1. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
Vigneri R; Sava L; Squatrito S; Sciacca L
Diabetes; 2010 Nov; 59(11):e24. PubMed ID: 20980466
[No Abstract] [Full Text] [Related]
2. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
Simon D; Balkau B
Diabetes; 2010 Nov; 59(11):e25. PubMed ID: 20980467
[No Abstract] [Full Text] [Related]
3. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
Carstensen B
Diabetes; 2010 Sep; 59(9):e17-8; author reply e19-22. PubMed ID: 20805379
[No Abstract] [Full Text] [Related]
4. Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry.
Yang X; So WY; Ma RC; Kong AP; Xu G; Chan JC
Diabetes Metab Res Rev; 2012 Jul; 28(5):379-87. PubMed ID: 22318884
[TBL] [Abstract][Full Text] [Related]
5. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.
Yang X; Ko GT; So WY; Ma RC; Yu LW; Kong AP; Zhao H; Chow CC; Tong PC; Chan JC
Diabetes; 2010 May; 59(5):1254-60. PubMed ID: 20185812
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of hyperglycemia and cancer risk: response to Stattin et al.
Bowker SL; Johnson JA
Diabetes Care; 2007 Jul; 30(7):e77; author reply e78. PubMed ID: 17596500
[No Abstract] [Full Text] [Related]
7. Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings--what, why and how?
Yang XL; Ma RC; So WY; Kong AP; Xu G; Chan JC
Diabetes Obes Metab; 2012 Jul; 14(7):579-85. PubMed ID: 22171706
[TBL] [Abstract][Full Text] [Related]
8. Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-The Hong Kong Diabetes Registry.
So WY; Yang X; Ma RC; Kong AP; Lam CW; Ho CS; Cockram CS; Ko GT; Chow CC; Wong V; Tong PC; Chan JC
Diabetes Metab Res Rev; 2008; 24(3):238-46. PubMed ID: 17992700
[TBL] [Abstract][Full Text] [Related]
9. Sense of coherence amongst Hong Kong Chinese adults with insulin-treated type 2 diabetes.
Shiu AT
Int J Nurs Stud; 2004 May; 41(4):387-96. PubMed ID: 15050850
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of hyperglycemia in adult-onset diabetes mellitus].
Yki-Järvinen H
Duodecim; 1999; 115(10):1155-64. PubMed ID: 11877855
[No Abstract] [Full Text] [Related]
11. Insulin glargine (Lantus) and cancer risk.
Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
[No Abstract] [Full Text] [Related]
12. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
Jellinger PS; Lebovitz HE; Davidson JA;
Diabetes Care; 2007 Apr; 30(4):e16-7; author reply e18-20, e21-2. PubMed ID: 17392531
[No Abstract] [Full Text] [Related]
13. Utilization of antidiabetic drugs in Hong Kong: relation to the common occurrence of antidiabetic drug-induced hypoglycemia amongst acute medical admissions and the relative prevalence of NIDDM.
Chan TY; Lee KK; Chan AW; Critchley JA
Int J Clin Pharmacol Ther; 1996 Jan; 34(1):43-6. PubMed ID: 8688996
[TBL] [Abstract][Full Text] [Related]
14. Comment and reply on: Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease.
Gude AB; Christiansen JS
Expert Opin Pharmacother; 2010 Jun; 11(9):1603-4; author reply 1604. PubMed ID: 20367274
[No Abstract] [Full Text] [Related]
15. Association of statin use and development of renal dysfunction in type 2 diabetes--the Hong Kong Diabetes Registry.
Luk AO; Yang X; Ma RC; Ng VW; Yu LW; Lau WW; Ozaki R; Chow FC; Kong AP; Tong PC; Chan JC; So W
Diabetes Res Clin Pract; 2010 Jun; 88(3):227-33. PubMed ID: 20236720
[TBL] [Abstract][Full Text] [Related]
16. [Diabetes, insulin, insulin analogues, and cancer].
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
[TBL] [Abstract][Full Text] [Related]
17. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea.
Chung YW; Han DS; Park KH; Eun CS; Yoo KS; Park CK
Dis Colon Rectum; 2008 May; 51(5):593-7. PubMed ID: 18219529
[TBL] [Abstract][Full Text] [Related]
18. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
Eizirik DL
Diabetes Care; 2009 Mar; 32(3):e35-6; author reply e37-8. PubMed ID: 19246586
[No Abstract] [Full Text] [Related]
19. Implications of the diabetes control and complications trial. American Diabetes Association.
J Fla Med Assoc; 1998 Aug; 85(2):22-4. PubMed ID: 9782715
[No Abstract] [Full Text] [Related]
20. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
Schiel R; Müller UA; Braun A; Stein G; Kath R
Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
